These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 35989136)
1. Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations. Laffan MA; Rees S; Yadavalli M; Ferstenberg LB; Kumar Shankar N; Medin J; Foskett N; Arnold M; Gomes da Silva H; Bhuyan P; Nord M Vaccine; 2022 Sep; 40(38):5585-5593. PubMed ID: 35989136 [TBL] [Abstract][Full Text] [Related]
2. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia. MacIntyre CR; Veness B; Berger D; Hamad N; Bari N Vaccine; 2021 Aug; 39(34):4784-4787. PubMed ID: 34272095 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccines and thrombosis with thrombocytopenia syndrome. Lai CC; Ko WC; Chen CJ; Chen PY; Huang YC; Lee PI; Hsueh PR Expert Rev Vaccines; 2021 Aug; 20(8):1027-1035. PubMed ID: 34176415 [TBL] [Abstract][Full Text] [Related]
4. Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review. Waqar U; Ahmed S; Gardezi SMHA; Tahir MS; Abidin ZU; Hussain A; Ali N; Mahmood SF Clin Appl Thromb Hemost; 2021; 27():10760296211068487. PubMed ID: 34907794 [TBL] [Abstract][Full Text] [Related]
5. Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada. Procter TD; Ogasawara H; Spruin S; Wijayasri S; Abraham N; Blaser C; Hutchings K; Shaw A; Ogunnaike-Cooke S Vaccine; 2023 Nov; 41(46):6802-6809. PubMed ID: 37806804 [TBL] [Abstract][Full Text] [Related]
6. Geographical distribution of TTS cases following AZD1222 (ChAdOx1 nCoV-19) vaccination. Soboleva K; Shankar NK; Yadavalli M; Ferreira C; Foskett N; Putsepp K; Ferstenberg LB; Nord M; da Silva HG; Bhuyan P Lancet Glob Health; 2022 Jan; 10(1):e33-e34. PubMed ID: 34919849 [No Abstract] [Full Text] [Related]
7. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. Long B; Bridwell R; Gottlieb M Am J Emerg Med; 2021 Nov; 49():58-61. PubMed ID: 34062319 [TBL] [Abstract][Full Text] [Related]
8. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. Sánchez van Kammen M; Aguiar de Sousa D; Poli S; Cordonnier C; Heldner MR; van de Munckhof A; Krzywicka K; van Haaps T; Ciccone A; Middeldorp S; Levi MM; Kremer Hovinga JA; Silvis S; Hiltunen S; Mansour M; Arauz A; Barboza MA; Field TS; Tsivgoulis G; Nagel S; Lindgren E; Tatlisumak T; Jood K; Putaala J; Ferro JM; Arnold M; Coutinho JM; ; Sharma AR; Elkady A; Negro A; Günther A; Gutschalk A; Schönenberger S; Buture A; Murphy S; Paiva Nunes A; Tiede A; Puthuppallil Philip A; Mengel A; Medina A; Hellström Vogel Å; Tawa A; Aujayeb A; Casolla B; Buck B; Zanferrari C; Garcia-Esperon C; Vayne C; Legault C; Pfrepper C; Tracol C; Soriano C; Guisado-Alonso D; Bougon D; Zimatore DS; Michalski D; Blacquiere D; Johansson E; Cuadrado-Godia E; De Maistre E; Carrera E; Vuillier F; Bonneville F; Giammello F; Bode FJ; Zimmerman J; d'Onofrio F; Grillo F; Cotton F; Caparros F; Puy L; Maier F; Gulli G; Frisullo G; Polkinghorne G; Franchineau G; Cangür H; Katzberg H; Sibon I; Baharoglu I; Brar J; Payen JF; Burrow J; Fernandes J; Schouten J; Althaus K; Garambois K; Derex L; Humbertjean L; Lebrato Hernandez L; Kellermair L; Morin Martin M; Petruzzellis M; Cotelli M; Dubois MC; Carvalho M; Wittstock M; Miranda M; Skjelland M; Bandettini di Poggio M; Scholz MJ; Raposo N; Kahnis R; Kruyt N; Huet O; Sharma P; Candelaresi P; Reiner P; Vieira R; Acampora R; Kern R; Leker R; Coutts S; Bal S; Sharma SS; Susen S; Cox T; Geeraerts T; Gattringer T; Bartsch T; Kleinig TJ; Dizonno V; Arslan Y JAMA Neurol; 2021 Nov; 78(11):1314-1323. PubMed ID: 34581763 [TBL] [Abstract][Full Text] [Related]
9. Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study. Hviid A; Hansen JV; Thiesson EM; Wohlfahrt J Ann Intern Med; 2022 Apr; 175(4):541-546. PubMed ID: 35103482 [TBL] [Abstract][Full Text] [Related]
10. Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021. See I; Lale A; Marquez P; Streiff MB; Wheeler AP; Tepper NK; Woo EJ; Broder KR; Edwards KM; Gallego R; Geller AI; Jackson KA; Sharma S; Talaat KR; Walter EB; Akpan IJ; Ortel TL; Urrutia VC; Walker SC; Yui JC; Shimabukuro TT; Mba-Jonas A; Su JR; Shay DK Ann Intern Med; 2022 Apr; 175(4):513-522. PubMed ID: 35038274 [TBL] [Abstract][Full Text] [Related]
11. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148 [TBL] [Abstract][Full Text] [Related]
12. Cerebral venous sinus thrombosis after adenovirus-vectored COVID-19 vaccination: review of the neurological-neuroradiological procedure. Wittstock M; Walter U; Volmer E; Storch A; Weber MA; Großmann A Neuroradiology; 2022 May; 64(5):865-874. PubMed ID: 35184205 [TBL] [Abstract][Full Text] [Related]
13. Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil. Mouta Nunes de Oliveira P; Mendes-de-Almeida DP; Bertollo Gomes Porto V; Crespo Cordeiro C; Vitiello Teixeira G; Saraiva Pedro R; Roberto Gomes Takey P; Kegele Lignani L; Reis Xavier J; Cardoso Doria da Gama V; Amorim Filho L; Emoingt Furtado B; Santa Maria A; Dahrug Barros T; Neves Waite Freitas L; Dos Santos Pereira T; Lima Abreu D; Bernardes Ramos M; Gabe C; Arnold D; William Smith J; Nazy I; Lourdes de Sousa Maia M; Vaccine; 2022 Aug; 40(33):4788-4795. PubMed ID: 35779962 [TBL] [Abstract][Full Text] [Related]
14. Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem. Clarke L; Brighton T; Chunilal SD; Lee CSM; Passam F; Curnow J; Chen VM; Tran HA Vaccine; 2023 May; 41(20):3285-3291. PubMed ID: 37085453 [TBL] [Abstract][Full Text] [Related]
15. Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India. Maramattom BV; Moidu FM; Varikkottil S; Syed AA BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34706921 [TBL] [Abstract][Full Text] [Related]
16. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response. Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315 [TBL] [Abstract][Full Text] [Related]
17. Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England. Whiteley WN; Ip S; Cooper JA; Bolton T; Keene S; Walker V; Denholm R; Akbari A; Omigie E; Hollings S; Di Angelantonio E; Denaxas S; Wood A; Sterne JAC; Sudlow C; PLoS Med; 2022 Feb; 19(2):e1003926. PubMed ID: 35192597 [TBL] [Abstract][Full Text] [Related]
18. Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data. Lane S; Shakir S Drug Saf; 2022 Sep; 45(9):1003-1008. PubMed ID: 35927605 [TBL] [Abstract][Full Text] [Related]
19. Fatal intracerebral haemorrhage associated with thrombosis with thrombocytopenia syndrome after ChAdOx1-S vaccine. Gómez-Roldós A; González-Sánchez M; Vales-Montero M; Vázquez-Alen P; Fernández-Bullido Y; Iglesias-Mohedano AM; Díaz-Otero F; García-Pastor A; Gil-Núñez A Rev Neurol; 2022 Oct; 75(7):199-202. PubMed ID: 36169326 [TBL] [Abstract][Full Text] [Related]
20. Central nervous system adverse events after ChAdOx1 vaccination. Maramattom BV; Lotlikar RS; Sukumaran S Neurol Sci; 2022 Jun; 43(6):3503-3507. PubMed ID: 35275317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]